Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
PD Dr. med. Wolfgang Schuette
With
Primary: * Proof of non-inferior efficacy of a monochemotherapy regimen of pemetrexed plus bevacizumab versus a combination chemotherapy regimen of pemetrexed-carboplatin plus bevacizumab in elderly patients(\> 65 years) as first-line treatment of advanced metastatic or recurrent non-squamous NSCLC by progression free survival Secondary: * To assess the efficacy of bevacizumab as measured by overall response rate and overall survival. * To assess the safety of bevacizumab in combination with pemetrexed and pemetrexed and carboplatin. * To assess quality of life by EORTC questionnaire QLQ-C30 and its lung cancer module LC-13 * To assess activity of daily life (iADL) in relation to ECOG performance status prior to study treatment * To assess patient's outcome and treatment delivery in relation to the Charlson comorbidity score and the Simplified Comorbidity Score
Age
65–any
Sex
ALL
Healthy volunteers
Not accepted
